These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 36004301)

  • 1. Postoperative Early Body Weight Loss Is a Risk Factor for Recurrence in Patients with pStage III Gastric Cancer.
    Fujimoto D; Taniguchi K; Takashima J; Kobayashi H
    Oncology; 2023; 101(11):705-713. PubMed ID: 37494910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of cortactin in patients with hypopharyngeal cancer and its role for tegafur-uracil maintenance after adjuvant chemoradiotherapy.
    Lien CF; Hwang TZ; Lin TM; Liu KW; Lin BS; Wang CC; Yang CC; Yeh SA; Hsieh MC
    Am J Cancer Res; 2023; 13(11):5504-5512. PubMed ID: 38058839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
    Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
    Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.
    Nomura K; Aokage K; Kaminuma Y; Nakai T; Wakabayashi M; Ikeno T; Koike Y; Taki T; Miyoshi T; Tane K; Samejima J; Ishii G; Tsuboi M
    Int J Clin Oncol; 2024 Mar; 29(3):248-257. PubMed ID: 38319510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery.
    Takei H; Kunitoh H; Wakabayashi M; Kataoka T; Sekino Y; Mizutani T; Tsuboi M; Ikeda N; Asamura H; Okada M; Takahama M; Ohde Y; Okami J; Shiono S; Aokage K; Watanabe SI;
    JTO Clin Res Rep; 2023 Aug; 4(8):100550. PubMed ID: 37600227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.
    Yamamoto H; Soh J; Okumura N; Suzuki H; Nakata M; Fujiwara T; Gemba K; Sano I; Fujinaga T; Kataoka M; Terazaki Y; Fujimoto N; Kataoka K; Kosaka S; Yamashita M; Inokawa H; Inoue M; Nakamura H; Yamashita Y; Hotta K; Yoshioka H; Morita S; Matsuo K; Sakamoto J; Date H; Toyooka S
    PLoS One; 2023; 18(5):e0285273. PubMed ID: 37205678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: When the field just moves on.
    Klapper JA
    JTCVS Open; 2020 Dec; 4():103-104. PubMed ID: 36004291
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary: When does the burden of treatment outweigh the biological benefit?
    Blumenthaler AN; Antonoff MB
    JTCVS Open; 2020 Dec; 4():105-106. PubMed ID: 36004287
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
    Okumura N; Soh J; Suzuki H; Nakata M; Fujiwara T; Nakamura H; Sonobe M; Fujinaga T; Kataoka K; Gemba K; Kataoka M; Hotta K; Yoshioka H; Matsuo K; Sakamoto J; Date H; Toyooka S
    BMC Cancer; 2021 May; 21(1):506. PubMed ID: 33957881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
    Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
    Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer.
    Watanabe T
    Breast Cancer; 2013 Oct; 20(4):302-9. PubMed ID: 23456736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Suehisa H; Toyooka S
    Acta Med Okayama; 2009 Oct; 63(5):223-30. PubMed ID: 19893597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707).
    Kunitoh H; Tsuboi M; Wakabayashi M; Okada M; Suzuki K; Watanabe SI; Asamura H;
    JTCVS Open; 2020 Dec; 4():90-102. PubMed ID: 36004301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Adjuvant Chemotherapy With Tegafur-Uracil in Patients With Completely Resected, Node-Negative NSCLC-Real-World Data in the Era of Molecularly Targeted Agents and Immunotherapy.
    Shukuya T; Takamochi K; Sakurai H; Yoh K; Hishida T; Tsuboi M; Goto Y; Kudo Y; Ohde Y; Okumura S; Taguri M; Kunitoh H
    JTO Clin Res Rep; 2022 May; 3(5):100320. PubMed ID: 35601927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
    Liang SK; Wu CW; Chang CI; Keng LT; Lee MR; Wang JY; Ko JC; Liao WY; Chen KY; Ho CC; Shih JY; Yu CJ
    Cancer Med; 2023 Sep; 12(17):17993-18004. PubMed ID: 37559409
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.